ICPO is a potent activator of herpes simplex virus type 1 gene expression in transient assays and in productive infection. A role for ICPO in reactivation from latency in vivo has also been suggested on the basis of the observation that viruses with mutations in both copies of the diploid gene for ICPO reactivate less efficiently than wild-type virus. Because the ICPO gene is contained entirely within the coding sequences for the latency-associated transcripts (LATs), ICPO mutants also contain mutations in LAT coding sequences. This overlap raises the question of whether mutations in ICPO or the LATs, which have also been implicated in reactivation, are responsible for the reduced reactivation frequencies characteristic of ICPO mutants. Two approaches were taken to examine more definitively the role of ICPO in the establishment and reactivation of latency. First, a series of ICPO nonsense, insertion, and deletion mutant viruses that exhibit graded levels of Expression of the herpes simplex virus type 1 (HSV-1) genome is regulated through two distinct and mutually exclusive programs that result in productive infection and latency. Productive infection involves the expression of all viral genes required to produce new progeny virus, whereas latency is characterized by the repression of nearly all viral gene expression such that only a series of overlapping transcripts, the latency-associated transcripts (LATs), is detected (12, 53, (55) (56) (57) . Identification of the factors that determine which program of viral gene expression is operative and those that mediate the switch from productive infection to latency and vice versa is central to understanding the pathogenesis of HSV.
ICPO is a potent activator of herpes simplex virus type 1 gene expression in transient assays and in productive infection. A role for ICPO in reactivation from latency in vivo has also been suggested on the basis of the observation that viruses with mutations in both copies of the diploid gene for ICPO reactivate less efficiently than wild-type virus. Because the ICPO gene is contained entirely within the coding sequences for the latency-associated transcripts (LATs), ICPO mutants also contain mutations in LAT coding sequences. This overlap raises the question of whether mutations in ICPO or the LATs, which have also been implicated in reactivation, are responsible for the reduced reactivation frequencies characteristic of ICPO mutants. Two approaches were taken to examine more definitively the role of ICPO in the establishment and reactivation of latency. First, a series of ICPO nonsense, insertion, and deletion mutant viruses that exhibit graded levels of ICPO-specific transactivating activity were tested for parameters of the establishment and reactivation of latency in a mouse ocular model. Although these mutants are ICPO LAT double mutants, all nonsense mutants induced the synthesis of near-wild-type levels of the 2-kb LAT, demonstrating that the nonsense linker did not disrupt the synthesis of this LAT species. All mutants replicated less efficiently than the wild-type virus in mouse eyes and ganglia during the acute phase of infection. The replication efficiencies of the mutants at these sites corresponded well with the ICPO transactivating activities of individual mutant peptides in transient expression assays. All mutants exhibited reduced reactivation frequencies relative to those of wild-type virus, and reactivation frequencies, like replication efficiencies in eyes and ganglia, correlated well with the level of ICPO transactivating activity exhibited by individual mutant peptides. The amount of DNA of the different mutants varied in latently infected ganglia, as demonstrated by polymerase chain reaction analysis. No correlation was evident between reactivation frequencies and the levels of viral DNA in latently infected ganglia. Thus, replication and reactivation efficiencies of ICPO mutant viruses correlated well with the transactivating efficiency of the corresponding mutant peptides. In a second approach to examining the role of ICPO in latency, a single copy of the wild-type gene for ICPO was inserted into the genome of an ICPO-LATdouble mutant, 7134, which exhibits a marked impairment in its ability to replicate in the mouse eye and reactivate from latency. Insertion of one copy of the ICPO gene into 7134 restored the ability of the mutant to replicate in the eye and reactivate from latency to approximately one-half of wild-type level. Together, these results demonstrate a role for ICPO distinct from the role of the IATs in the establishment and reactivation of latency.
Expression of the herpes simplex virus type 1 (HSV-1) genome is regulated through two distinct and mutually exclusive programs that result in productive infection and latency. Productive infection involves the expression of all viral genes required to produce new progeny virus, whereas latency is characterized by the repression of nearly all viral gene expression such that only a series of overlapping transcripts, the latency-associated transcripts (LATs), is detected (12, 53, (55) (56) (57) . Identification of the factors that determine which program of viral gene expression is operative and those that mediate the switch from productive infection to latency and vice versa is central to understanding the pathogenesis of HSV.
The studies described in this report are concerned with the role of ICPO, an immediate-early (IE) regulatory protein, in expression of any gene that exhibits a basal level of transcription (1-3, 5, 15-19, 21, 30, 38-41, 43, 47, 52, 54) . The phenotypic properties of ICPO mutant viruses during productive infection indicate that this protein plays a fundamental role in enhancing the expression of E and L genes (3, 5) but appears to play a more limited role in enhancing IE gene expression (3) . The (51) . 7134 (1) and d1x3.1 (47) are ICPO null mutants (Fig. 1) . The former contains the lacZ coding region in place of the ICPO coding region, and the latter contains a large deletion in the ICPO gene. Viruses n212, n428, n525, n680, n720, and n770 contain nonsense mutations in the ICPO gene (1). 7134R was generated by replacing the lacZ gene in 7134 with wild-type ICPO DNA sequences (1) . The isolation of mutant 171 will be described below. diLAT1.8 is a LAT null mutant isolated by Leib et al. (27) . Plasmids [42] ) specific for LATs cloned into pGEM3Zf(+) (Fig. IE) .
Animal procedures. CD-1 mice were infected by the ocular route with wild-type or mutant viruses as described previously (28) . Virus solution (SFMH containing 0.125% trypsin and 0.02% collagenase) by shaking in a water bath at 37°C. After 20 min, dissociated cells in suspension were decanted into Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. Fresh enzyme solution was added to the remaining ganglion pieces for further digestion. After three rounds of digestion, dissociated cells were pelleted and resuspended in 3 ml of SFMH containing 10% fetal bovine serum and 5% horse serum, seeded into Matrigel (Collaborative Research, Inc., Bedford, Mass.)-coated six-well plates, and incubated at 37°C overnight. The replication-incompetent ICP27 deletion mutant virus 5d11.2 (5 x 106 PFU in 0.5 ml) was added to the ganglionic cell monolayer (approximately 1 x 106 cells) and incubated at 37°C for 1 h. The inoculum was removed, and 5 x 105 Vero cells in 3 ml of growth medium were added. Growth medium containing 2% hydroxymethyl cellulose was applied to the cell monolayer 3 h later, and plaques that developed in 4 days were counted and recorded.
Quantitation of viral DNA in latently infected ganglia. Ganglia were removed from mice on day 30 postinfection, total DNA (approximately 2.5 ,ug per ganglion) was isolated, and viral DNA in total ganglionic DNA was quantified by polymerase chain reaction (PCR) as described previously (8, 26) . The signals from the single-copy mouse gene amplified together with viral DNA were similar in all samples.
RESULTS
Properties of the ICPO and LAT mutants used in these studies. The ICPO and LAT genes are present in both copies of the b inverted repeat sequences surrounding the unique long region of the viral genome and are transcribed from opposite strands ( Fig. 1A to C) (12, 14, 20, 53, (55) (56) (57) (58) (59) . The 3' terminus of the ICPO mRNA overlaps the 2.0-kb, poly(A) -LATs by approximately 1 kb (Fig. 1C) . Furthermore, the three coding exons that specify the 775-amino-acid ICPO protein are contained entirely within sequences encoding the large, poly(A)+ LATs, which have been postulated to be the precursors of the shorter poly(A) -LATs (56, 57) . By definition, therefore, ICPO mutants are also mutated in sequences specifying the LATs.
One approach that can be taken to assess the role of ICPO in latency and reactivation independent of the role of the LATs in " The transactivating activities of the peptides specified by ICPO nonsense mutant plasmids used to generate ICPO mutant viruses, on a scale from -(no transactivation) to +++ (strong transactivation), are summarized from the data of Cai and Schaffer (1).
h For reactivation studies with mutant viruses, mice were inoculated with 2 x 106 PFU of each virus per eye (28) . On day 30 postinfection trigeminal ganglia were removed, cut into approximately eight small pieces, and cocultivated with Vero cells for 5 days. Virus production during cocultivation was detected on 0-28 cells. Individual ganglia were considered to have reactivated if cytopathic effect was observed. The reactivation frequency is the ratio of the number of ganglia from which virus reactivated in the 5-day cocultivation test to the total number of ganglia tested.
' Results of x2 tests to determine the significance of differences in reactivation frequencies of mutants relative to KOS. P values of <t).05 are considered significant. these processes is to characterize a series of mutant viruses that exhibit graded levels of ICPO activity in vitro and minimally perturb LAT coding sequences. Using such mutants, one can determine whether the ICPO transactivating activity of mutant plasmids can be correlated with the ability of the corresponding mutant viruses to establish and reactivate from latency.
For this purpose, a series of KOS-derived nonsense mutants (n212, n428, n525, n680, n720, and n770) were used in these studies. Five of the six mutants produce truncated ICPO peptides of the expected sizes (427, 524, 679, 719, and 769 amino acid residues, respectively) (1). The 211-amino-acid n212 peptide has not been detected. With the exception of the n212 peptide, which exhibited no detectable ICPO activity for HSV-1 promoters either in transient expression assays (1) or in tests designed to measure enhancement of viral gene expression (3), the ICPO peptides specified by the mutants exhibit graded levels of transactivating activity relative to that of wild-type ICPO (1) ( Table 1 ). In general, the longer the mutant ICPO peptide is, the greater is its transactivating activity in transient expression assays (1) . In addition to mutations in ICPO coding sequences, n680, n720, and n770 also contain the nonsense linker in the large potential open reading frame (ORF-1) of the 2-kb poly(A) -LATs ( Fig. IC and D) . The mutations in n212, n428, and n525, on the other hand, are located far upstream of the 3' terminus of the poly(A) -LATs but are present within sequences specifying the large poly(A)+ LATs ( Fig. IC and D) . In mutant 7134, both copies of the ICPO coding region have been replaced with the coding region of the lacZ gene, whereas in dlx3. 1, a region of 2,965 bp, including the ICPO transcription initiation site (i.e., from nucleotides 1808 to 2722 and from nucleotides 121,602 to 124,566 in the b repeat regions [42] ) has been deleted. Like n212, both 7134 and dlx3.1 exhibit no detectable ICPO transactivating activity (Table 1) ; of these three mutants, only the mutation in 7134 extends into the poly(A) -LAT region ( Fig. IC and D) .
The LAT-minus mutant dlLAT1.8 was also included in this study. In this mutant, sequences containing the LAT promoter and transcription start site have been deleted (Fig. IC and D pressed the 2-kb LATs. These studies show that the nonsense linkers within the ICPO genes of these mutants appear to have little or no effect on 2-kb LAT expression. If the LATs encode a protein, however, these linkers may alter the function of this protein.
Replication of ICPO nonsense mutants in the eye and in ganglia during acute infection in vivo. Having previously determined the relative transactivating activities of nonsense mutant peptides in transient expression assays (Table 1) (1) and having demonstrated that the mutants induce the synthesis of the 2-kb LATs (Fig. 2) , we next asked to what extent they replicated in an animal model. For this purpose we determined the titers of virus in eye swabs and in ganglia during the acute phase of infection in a mouse ocular model of latency (Fig. 3) . The viral titers determined on day 3 postinfection represent progeny rather than input virus, because input virus is barely detectable in eyes by 3 h postinfection (28) . In transient expression assays, the wild-type and 7134R forms of ICPO exhibited equally high levels of transactivating activity (Table  1) , and the viruses containing these ICPO genes replicated with nearly equal efficiency in eyes and in ganglia (Fig. 3) . In contrast, plasmids containing a substitution or a deletion in the ICPO gene (7134 and dlx3.1, respectively) exhibited no ICPO transactivating activity in transient assays (Table 1) , and the viruses containing these mutated ICPO genes replicated poorly in eyes but somewhat better in ganglia on day 3 postinfection. Like 7134 and dlx3.1, the nonsense mutant n212, the ICPO gene of which specifies no detectable transactivating activity (Table 1) , replicated poorly in both eyes and ganglia. The n428 ICPO gene specifies only low levels of ICPO-associated transactivating activity (Table 1) . Mutant n428 replicated poorly in eyes and ganglia but somewhat more efficiently than n212. Longer ICPO peptides (i.e., those specified by n525 and n680) exhibited transactivating activities similar to that of n428 (Table 1 ) and replicated more efficiently in ganglia but less efficiently in eyes than n428. The replication efficiency of n720, whose ICPO-associated transactivating activity is moderately high (Table 1) , was nearly identical in eyes and ganglia to the replication efficiencies of n525 and n680 (Fig. 3) . Finally, n770 is similar to wild-type virus with regard to the ICPO-associated transactivating activity it specifies (Table 1) and its ability to replicate in eyes and ganglia (Fig. 3) . The discordance in the titers of n525, ni680, and n720 obtained in eyes and in ganglia is of interest. One might predict that the nonsense mutations in these mutants would affect the efficiency of replication at the two sites equally. The fact that some mutations had a greater effect on the ability of mutant viruses to replicate in eyes than in ganglia suggests either that factors regulating viral growth in eyes and in ganglia differ or that our assay for measuring virus replication in eyes on day 3 is less discriminating than the assay that measures virus replication in ganglia.
We conclude from these tests that (i) replication efficiency in ganglia correlates well with the length of the ICPO peptide and the level of ICPO-associated transactivating activity expressed by the mutant peptide in transient assays and (ii) some ICPO-LAT mutants are more affected for replication in the eye than in ganglia (e.g., ,z520, ni680, and n720). To determine the levels of viral DNA in ganglia, total ganglionic DNA was isolated from individual ganglia and viral DNA sequences were amplified by quantitative PCR (Fig. 4) . Viral DNA was present in individual ganglia latently infected with KOS at levels ranging from approximately 200 to greater than 2,000 copies per 100 ng of ganglionic DNA. (Approximately 2.5 ,ug of DNA was obtained from individual ganglia.) As in the case of ganglia latently infected with KOS, the levels of mutant viral DNA in ganglia varied considerably from ganglion to ganglion. Thus, in n212-infected ganglia, copy numbers ranged from 200 to 2,000, and in 7134-and n525-infected ganglia, copy numbers ranged from no detectable DNA to -600 copies per 100 ng. On average, there was less viral DNA in 7134-and n525-infected ganglia than in n212- (28, 31) . Activation of latent genomes by complementation and recombination mechanisms with SdlI.2 has been described previously (28) . Although the number of plaques produced following superinfection reflects the relative number of cells in individual ganglia containing retrievable viral genomes, the actual number of genome-containing cells is likely greater than the number of cells that score positive in this test. Because of the complexity of the dissociation assay, in addition to KOSinfected ganglia, we chose to test only n212-and n525-infected ganglia because they contained the most and the fewest viral genomes per ganglion, respectively (Fig. 4) .
The number of plaques produced following superinfection of ganglionic cells containing n525 DNA was nearly the same as for ganglionic cells containing KOS DNA (Fig. 5) . Furthermore, virus was retreived from nearly all ganglia from n525-infected mice (the exception being 2 of 12 ganglia). Ganglia latently infected with n212 yielded fewer plaques per ganglion, but all ganglia yielded some plaques. We conclude from these studies that the ICPO nonsense mutants ni212 and ni525 establish latent infection in nearly as many ganglia and in nearly as many cells per ganglion as wild-type virus. A comparison of these data with the data concerning genome copy number (Fig.  4) , reactivation frequency, and relative ICPO transactivating activity (Table 1) indicates that reactivation frequency correlates best with ICPO transactivating activity and not with genome copy number or the number of cells containing reactivatable viral genomes.
Insertion of one copy of the wild-type ICPO gene into a distant site in the genome of an ICPO-LAT-mutant. As mentioned above, reactivation data obtained from mice latently infected with viruses containing mutations in the ICPO-LAT region is difficult to interpret with regard to the role of ICPO in this process because these mutants are by definition double mutants. Although the ability of the mutants to replicate during acute infection and to reactivate from latency in vivo correlates well with the activity of the ICPO peptide, more definitive evidence establishing a role for ICPO in latency and reactivation was obtained by providing ICPO function, but not LAT function, to an ICPO LATh mutant, 7134. In these studies, ICPO function was partially restored to 7134 by insertion of a single copy of the ICPO gene into the genome at a site distant from the mutations in the ICPO and LAT genes. As the first step in generating such a virus, plasmid pW3F was constructed (Fig. 6) . PW3F contains the entire ICPO gene flanked by sequences in the UL26 and UL27 genes. Thus, the 4.5-kb StWll-HpaI fragment also contains the ICPO coding region as well as 0.9-kb 5'-and 0.4-kb 3'-flanking sequences that are sufficient for ICPO expression in transient expression assays (1; unpublished observations). This fragment contains a subset of LAT coding sequences without the LAT promoter and expresses no detectable LATs (data not shown). The flanking sequences on the left and right of the StiI-HpaI fragment in Fig. 6 should contain sufficient information for polyadenylation of the UL24, UL25, UL26, and UL26.5 and the UL27, UL28, and UL29 transcripts, respectively, and sufficient sequence length for insertion between the UL26 and UL27 genes by homologous recombination.
The HSV-1 sequences in pW3F were introduced into the genome of 7134 by homologous recombination to yield mutant 171, and the structure of 171 DNA was verified by Southern blot analysis (Fig. 7) . By using viral DNA sequences adjacent to the Stul-HpaI fragment containing the ICPO gene as a probe (Fig. 7B, probe 1) , a 3.2-kb SacI-PstI fragment was identified in 171 and 7134 DNA and a 6.2-kb fragment was identified in KOS DNA (Fig. 7) . By using probe 2, which is specific for the ICPO gene (Fig. 7B) , fragments of the same sizes were identified (Fig. 7A ). In addition, probe 2 identified a 2.9-kb PstI-SacI fragment in 7134 and 171 which reflects the presence of the lacZ gene (Fig. 7) . Probe 2 also identified a 5.8-kb PstI fragment in 171 DNA; this fragment demonstrates the presence of the ICPO gene between the UL26 and UL27 genes.
Finally, sequences from the UL26-UL27 region (probe 3) identified the 5.8-kb fragment in 171 DNA and a 1.1-kb Pstl fragment in KOS and 7134 DNAs. These restriction patterns are in agreement with the predicted genomic structures of the three viruses (Fig. 7B) . Mutant 171 produces uniform blue plaques in the presence of X-Gal (5-bromo-4-chloro-3-indolyl-P-D-galactopyranoside), as does its parent virus, 7134, indicating the presence of the lacZ gene in both viruses (data not shown).
Characterization of mutant 171 during productive infection in vitro. The wild-type ICPO (Fig. 7) . Horizontal arrows indicate the direction of transcription and the sites of transcription termination for two groups of coterminal transcripts (UL24, UL25, and UL26 and UL27, UL28, and UL29). The construction of pW3F is described in detail (Fig. 8) . As previously observed, 7134 produced fewer progeny virus than KOS, and the replication deficiency was more pronounced at the low multiplicity of infection (0.01 PFU per cell) than at the high multiplicity (2.5 PFU per cell) (3). Yields of 171 progeny virus were near the midpoint between those of 7134 and KOS at both multiplicities. Thus, the single ICP0 gene in 171 partially reverses the replication-impaired phenotype of 7134. The failure of 171 to express the wild-type growth phenotype is due more likely to the fact that only one copy of the ICP0 gene was introduced into 7134 DNA or to one or more of the factors mentioned above than to the presence of the mutation in the LAT gene in 171 and 7134. Elimination of LAT expression produced no obvious growth phenotype at either high or low multiplicity during productive infection in vitro (1, 27) .
To measure the level of expression of ICP0 and of other viral proteins in 171-infected cells, Vero cells were infected with 171 or KOS, and selected viral proteins were immunoprecipitated and analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (Fig. 9) Fig. 2 and Table 1 were repeated using 171, 7134, d1LATI.8, and KOS ( Fig. 10 and Table 2 ). The titers of 171 in eye swabs and ganglia during acute infection were higher than those of 7134 and lower than those of KOS (Fig. 10) . Therefore, insertion of one copy of the ICPO gene into the genome of 7134 partially reversed the replication defect of this mutant during acute infection in mice, indicating that ICP0 is important for virus replication in eyes and in ganglia. As an ICP0+ LAT--control, d/LATI.8 produced nearly the same levels of virus as KOS in both eyes and ganglia, as reported previously (27) . This result further substantiates the hypothesis that the primary replication deficiencies of 7134 and 171 result from mutations in ICPO and not the LATs.
The levels of viral DNA in ganglia of mice infected 30 days previously with 171 were assessed by quantitative PCR (Fig. 4) . These levels ranged from no detectable DNA to >2,000 copies per 100 ng of ganglionic DNA. On the average, these levels approximated those in KOS-infected ganglia but were higher than those in 7134-infected ganglia.
As for growth in cell culture and growth in eyes and ganglia during acute infection of mice, the frequency of reactivation of 171 from latency was significantly higher than that of 7134 (P = 0.005) and somewhat lower than that of KOS ( Table 2 ). The mutation in dlLAT1.8 reduced the frequency of reactivation by approximately 50%, as reported previously (27) . Although the LAT mutations in 171 and 7134 also affect the frequency of reactivation, these mutations are identical in both viruses. Consequently, the difference in the frequency of reactivation of these two viruses is most likely due to the presence of the single copy of the ICPO gene in 171. latently infected cells were comparable as judged by PCR analysis. Similarly, the number of genomes in ganglia latently infected with n212 was somewhat greater than that in n525-infected ganglia, yet n525 reactivated more efficiently than did n212. These observations indicate that the role of ICPO in reactivation is to enhance not only the number of genomes in latently infected ganglia but also the level of ICPO transactivating activity. We conclude therefore that in addition to its role in enhancing virus replication during the acute stages of infection, ICPO plays an important role in reactivation.
DISCUSSION

